))
Aida Perramon-Malavez and Antoni Soriano-Arandes on the real-world impact of nirsevimab
Manage episode 498227791 series 3678747
Content provided by The Lancet Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Lancet Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Can nirsevimab transform prevention strategies for respiratory infection in infants? Join Stephanie Becker as she sits down with Aida Perramon-Malavez and Antoni Soriano-Arandes to explore the significant threat that respiratory syncytial virus (RSV) poses to young children.
Discover insights into the real-world impact of nirsevimab implementation during its first season, explore how prevention strategies vary across Europe, and hear about the urgent need for equitable access to vaccination worldwide.
Read the full article:
6 episodes
Share
